Top 5 Blue Chip Stocks To Invest In 2018

The U.S. economy is expected to strengthen next year, in part because of the government stimulus proposed at by President-elect Donald Trump, but job growth is likely to slow as the recovery approaches its eighth anniversary, according to a recent survey of economists.

The economy is projected to grow at a 2.3% annual rate in 2017, up from an estimated 1.6% this year, according to the average forecast of 53 economists surveyed earlier this month by Blue Chip Economic Indicators. Thats modestly above the tepid 2.1% average that has prevailed since the Great Recession ended in June 2009.

The big wild card: the Trump effect. Quick congressional passage and implementation of his plan to sharply increase infrastructure and defense spending and slashtaxes could mean faster growth. But delays or a significant scale-down by lawmakers could leave the higher interest rates his blueprint already has triggered without the benefits. And Trumps threats to slap big tariffs on China and Mexico risk trade wars that could further roil the economy.

Top 5 Blue Chip Stocks To Invest In 2018: Sun Life Financial Inc.(SLF)

Advisors’ Opinion:

  • [By Lee Jackson]

    Sun Life Financial Inc. (NYSE: SLF) was downgraded to Hold from Buy at Argus. The 52-week trading range is $25.31 to $39.87. The consensus price target is $39.48. The shares closed at $38.65, so this could be a valuation call.

Top 5 Blue Chip Stocks To Invest In 2018: Viking Therapeutics, Inc.(VKTX)

Advisors’ Opinion:

  • [By George Budwell]

    Shares of Viking Therapeutics (NASDAQ:VKTX), a clinical-stage biotech developing treatments for endocrine and metabolic disorders,dropped by 30.1% last month,according toS&P Global Market Intelligence. What’s all the fuss about?

  • [By Lisa Levin]

    Viking Therapeutics Inc (NASDAQ: VKTX) shares dropped 39 percent to $1.17 after the company priced 7.5 million share offering at $1.25 per share.

  • [By William Romov]

    Currently trading at $4.52 per share, Viking Therapeutics Inc. (Nasdaq: VKTX) develops drugs to treat fatty liver disease and post-hip surgery rehabilitation. It has the highest share price of the penny stocks on our list today.

  • [By Lisa Levin]

     

    Losers
    DBV Technologies SA – ADR (NASDAQ: DBVT) shares tumbled 50.6 percent to $23.73 after the company disclosed that its peanut allergy trial failed to meet primary endpoint.
    Connecture Inc (NASDAQ: CNXR) shares declined 40.8 percent to $0.290. Connecture reported that it will voluntarily delist from the NASDAQ for OTCQX Market.
    Walter Investment Management Corp (NYSE: WAC) slipped 19.2 percent to $0.410. On Friday, Walter Investment Management disclosed that it has reached an agreement with term lenders and senior noteholders on financial restructuring.
    Eldorado Gold Corp (USA) (NYSE: EGO) shares dropped 15.9 percent to $1.83. Eldorado Gold lowered its production guidance for its Kisladag operation.
    Seanergy Maritime Holdings Corp. (NASDAQ: SHIP) shares fell 15.4 percent to $1.04.
    Future Fintech Group Inc (NASDAQ: FTFT) dropped 13.6 percent to $1.53. Future FinTech reported filing of proxy statement, including proposal for corporate restructuring.
    Concordia International Corp (NASDAQ: CXRX) shares fell 12.3 percent to $0.500 after dipping 38.71 percent on Friday.
    Aemetis Inc (NASDAQ: AMTX) shares declined 11.3 percent to $0.550
    OncoSec Medical Inc (NASDAQ: ONCS) dipped 10.5 percent to $1.12. OncoSec reported a $7.1 million registered direct at-the-market offering at a price of $1.34375 per share.
    Evoke Pharma Inc (NASDAQ: EVOK) shares fell 10.35 percent to $3.08 after the company disclosed 'positive' topline results from comparative exposure pharmacokinetic study for Gimoti.
    Eiger Biopharmaceuticals Inc (NASDAQ: EIGR) shares dropped 9.4 percent to $11.60 as the company disclosed Phase 2 interim 24-week data with pegylated interferon lambda in Hepatitis Delta Virus infection at the American Association for the Study of Liver Diseases Meeting.
    Viking Therapeutics Inc (NASDAQ: VKTX) shares slipped 6.6 percent to $2.80. Viking Therapeutics presented results from proof-of-concept study of VK0214 in in vivo

Top 5 Blue Chip Stocks To Invest In 2018: Electro Scientific Industries, Inc.(ESIO)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Wednesday, our Elite Opportunity Pro (EOP) portfolio newsletter has suggestedsmall cap laser-based manufacturing solutions stockElectro Scientific Industries (NASDAQ: ESIO). According tothe Company itself: Its integrated solutions allow industrial designers and process engineers to control the power of laser light to transform materials in ways that differentiate their consumer electronics, wearable devices, semiconductor circuits and high-precision components for market advantage. The Company’s laser-based manufacturing solutions feature the micro-machining industry’s highest precision and speed, and target the lowest total cost of ownership.To put that more into layman terms: Electro Scientific Industries systems enable precise engineering and testing of micron to submicron features in semiconductors, LEDs, multi-layer ceramic capacitors (MLCCs), printed circuit boards (PCBs), flex circuits and other high-value components – all of which are vital to our economy.

Top 5 Blue Chip Stocks To Invest In 2018: AECOM(ACM)

Advisors’ Opinion:

  • [By Lisa Levin] Companies Reporting Before The Bell
    Tyson Foods, Inc. (NYSE: TSN) is expected to report quarterly earnings at $1.38 per share on revenue of $9.86 billion.
    Aecom (NYSE: ACM) is projected to report quarterly earnings at $0.71 per share on revenue of $4.67 billion.
    JD.Com Inc(ADR) (NASDAQ: JD) is estimated to report quarterly earnings at $0.11 per share on revenue of $12.60 billion.
    58.com Inc (ADR) (NYSE: WUBA) is projected to report quarterly earnings at $0.28 per share on revenue of $383.60 million.
    Kamada Ltd (NASDAQ: KMDA) is expected to report quarterly earnings at $0.02 per share on revenue of $25.00 million.
    Palatin Technologies, Inc. (NYSE: PTN) is projected to report quarterly earnings at $0.06 per share on revenue of $28.00 million.
    TheStreet, Inc. (NASDAQ: TST) is estimated to report a quarterly loss at $0.02 per share on revenue of $15.81 million.
    Atlantica Yield PLC (NASDAQ: ABY) is projected to report quarterly earnings at $0.45 per share on revenue of $290.80 million.
    Asure Software Inc (NASDAQ: ASUR) is estimated to report quarterly earnings at $0.15 per share on revenue of $15.26 million.
    Cyren Ltd (NASDAQ: CYRN) is expected to report quarterly loss at $0.06 per share on revenue of $7.90 million.
    Viewray Inc (NASDAQ: VRAY) is estimated to report quarterly loss at $0.12 per share on revenue of $18.58 million.

     

  • [By Jon C. Ogg]

    AECOM (NYSE: ACM) offers architecture and engineering design services and operates through three segments: Design and Consulting Services, Construction Services, and Management Services. It services the transportation, environmental and energy sectors, and it also serves key infrastructure projects such as highways, airports, bridges, wastewater facilities and power transmission and distribution. This puts AECOM right in the major infrastructure investing crosshairs for what you can expect ahead.

  • [By Rafi Farber]

    Jack of all trades infrastructure firm AECOM (NYSE: ACM) closed at $27.88 the afternoon everyone thought it would be Clinton by a landslide. Since then, the stock has exploded by 35%. Runs like this for AECOM, while extreme, are not unheard of, as a long-term chart shows quite heavy volatility going back to 2007.

Top 5 Blue Chip Stocks To Invest In 2018: Grupo Aeroportuario Del Pacifico, S.A. de C.V.(PAC)

Advisors’ Opinion:

  • [By Asit Sharma]

    In its fourth-quarter 2016 earnings filed on Feb. 23, Grupo Aeroportuario del PacificoSAB de CV(NYSE:PAC)capped a year of growth across several important metrics. The Mexican airport operator, which abbreviates its name to GAP, reported increases in revenue, profits, and domestic and international passenger traffic.

Leave a Reply

Your email address will not be published. Required fields are marked *